Trade

with

Sequenom Inc
(NASDAQ: SQNM)
AdChoices
3.27
-0.07
-2.10%
After Hours :
3.27
0.00
0.00%

Open

3.36

Previous Close

3.34

Volume (Avg)

1.07M (1.79M)

Day's Range

3.23-3.36

52Wk Range

1.65-4.17

Market Cap.

381.52M

Dividend Rate ( Yield )

-

Beta

0.91

Shares Outstanding

116.67M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 162.43M

    • Net Income

    • -107.41M

    • Market Cap.

    • 381.52M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -31.37

    • PEG (Price/Earnings Growth) Ratio

    • 1.29

    • Beta

    • 0.91

    • Forward P/E

    • 34.36

    • Price/Sales

    • 2.04

    • Price/Book Value

    • -7.73

    • Price/Cash flow

    • -7.79

      • EBITDA

      • -83.29M

      • Return on Capital %

      • -35.91

      • Return on Equity %

      • -

      • Return on Assets %

      • -35.91

      • Book Value/Share

      • -0.42

      • Shares Outstanding

      • 116.67M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 5.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 0.06

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 62.20

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 28.07

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 42.80

            • 82.75

            • Pre-Tax Margin

            • -42.31

            • 39.38

            • Net Profit Margin

            • -31.37

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 49.40

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -154.20

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -154.30

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 2.15

              • 2.92

              • Quick Ratio

              • 1.96

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • -

              • 2.21

              • Book Value/Share

              • -0.42

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -5.27

                • 196.08

                • P/E Ratio 5-Year High

                • -14.04

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.66

                • 124.82

                • Price/Sales Ratio

                • 2.04

                • 9.12

                • Price/Book Value

                • -7.73

                • 8.26

                • Price/Cash Flow Ratio

                • -7.79

                • 47.39

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -

                        (-2,940.70)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -35.91

                        (-63.70)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -

                        (-79.20)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 8.35

                      • 1.48

                      • Asset Turnover

                      • 1.14

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -98.41M
                      Operating Margin
                      -60.59
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -7.79
                      Ownership

                      Institutional Ownership

                      43.11%

                      Top 10 Institutions

                      31.66%

                      Mutual Fund Ownership

                      17.57%

                      Float

                      98.96%

                      5% / Insider Ownership

                      1.55%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Small Cap Index

                      •  

                        2,034,690

                      • 0.32

                      • 1.74

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,895,619

                      • 1.41

                      • 1.62

                      • iShares Russell 2000 (AU)

                      •  

                        1,800,552

                      • -1.02

                      • 1.74

                      • iShares Nasdaq Biotechnology

                      •  

                        1,548,775

                      • -0.69

                      • 1.49

                      • UBS (Lux) EF Biotech (USD)

                      •  

                        1,508,400

                      • 0.00

                      • 1.29

                      • Merchfondo FI

                      •  

                        1,400,000

                      • 0.00

                      • 1.20

                      • Vanguard Small Cap Growth Index Fund

                      •  

                        1,369,338

                      • -1.84

                      • 1.17

                      • Vanguard Extended Market Index Fund

                      •  

                        1,120,327

                      • 0.42

                      • 0.96

                      • iShares Russell 2000 Growth

                      •  

                        837,947

                      • -2.72

                      • 0.81

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Palo Alto Investors, LLC

                      •  

                        9,810,442

                      • -49.89%

                      • 8.41

                      • Vanguard Group, Inc.

                      •  

                        6,985,515

                      • +0.34%

                      • 5.99

                      • Camber Capital Management LLC

                      •  

                        6,300,000

                      • +116.38%

                      • 5.40

                      • BlackRock Fund Advisors

                      •  

                        4,262,058

                      • -1.73%

                      • 3.65

                      • Proxima Capital Management, LLC

                      •  

                        2,161,876

                      • -2.26%

                      • 1.85

                      • State Street Corp

                      •  

                        1,939,725

                      • -0.73%

                      • 1.66

                      • UBS Global Asset Management Zurich

                      •  

                        1,554,296

                      • 0.00%

                      • 1.33

                      • Merchbanc SGIIC

                      •  

                        1,450,000

                      • 0.00%

                      • 1.25

                      • Northern Trust Investments, N.A.

                      •  

                        1,405,435

                      • -9.17%

                      • 1.21

                      • Millennium Management LLC

                      •  

                        1,066,516

                      • +1.16%

                      • 0.91

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      Sequenom Inc was incorporated in 1994 under the laws of the State of Delaware. It is a life sciences company providing revolutionary genomic and genetic analysis solutions for the molecular diagnostic and clinical research markets. I...moret develop and commercialize molecular diagnostics testing services that target and serve molecular diagnostics markets, and also develop and commercialize research use genetic analysis products and services that target and serve discovery and clinical research markets. It offers its services and products in the United States and international emphasis in countries like European and Asia-Pacific regions. The Company operates in two operating segments; Sequenom Laboratories and Sequenom Bioscience. Sequenom Laboratories provides molecular based, laboratory developed tests,...more or LDTs, with a focus principally on prenatal diseases and conditions and ophthalmological diseases and conditions. Sequenom Bioscience provides technology and research tools for genetic analysis and applications in translational research, clinical research, pharmacogenomics, oncology, and agricultural genomics. The Company's competitors include; Ariosa Diagnostics, Inc., Beijing Genomics Institute, Cellscape Corp., Celula Inc., Ikonysis, Inc., Kellbenx, Inc., Laboratory Corporation of America Holdings, Inc., Natera, Perkin Elmer, Inc., Quest Laboratories, Verinata and others. Its patent portfolio, including in-licensed patent rights, includes approximately 638 issued or allowed patents in the United States and other industrial nations throughout the world. Its prenatal diagnostic patent portfolio includes exclusive rights to numerous in-licensed issued patents. The Company is subject to federal, state and local laws and regulations governing the use, storage, handling and disposal of such materials and chemicals, as well as certain waste products.lessless

                      Key People

                      William J. Welch

                      CEO/Director/President

                      Dr. Harry F. Hixson

                      Chairman of the Board/Director

                      Ms. Carolyn D. Beaver

                      CFO/Chief Accounting Officer/Vice President

                      Ms. Alisa Judge

                      Vice President, Divisional

                      Dr. Ronald M. Lindsay, PhD

                      Director

                      • Sequenom Inc

                      • 3595 John Hopkins Court

                      • San Diego, CA 92121

                      • USA.Map

                      • Phone: +1 858 202-9000

                      • Fax: +1 858 202-9001

                      • sequenom.com

                      Incorporated

                      1994

                      Employees

                      570

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: